Kabidarba 40 Injection
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Kabidarba 40 Injection
Erythropoietin (Kabidarba 40 Injection) treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves stimulating red blood cell production within the bone marrow. This medication requires careful administration due to potential severe adverse reactions; expert medical supervision is crucial. Adhere rigorously to your physician's instructions. Administered under professional healthcare oversight, common side effects include abdominal discomfort, hypertension, skin rash, injection site soreness, dyspnea, cough, and peripheral swelling. Report symptoms suggestive of dangerously elevated blood pressure – intense headache, visual disturbances, nausea, vomiting, or convulsions – immediately. Regular blood tests will monitor electrolyte (potassium) levels, hemoglobin, and blood cell counts. Discontinue use and seek medical attention for sudden shortness of breath or a skin eruption. Prior to commencing treatment, disclose any history of cardiac disease, hypertension, seizures, or stroke. Pregnant, breastfeeding, or planning pregnancy/breastfeeding women should consult their doctor regarding its safety.
Uses of Kabidarba 40 Injection
Managing anemia in patients with chronic kidney disease | Addressing chemotherapy-induced anemia
Major Benefits of Kabidarba 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Kabidarba 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Kabidarba 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Kabidarba 40 Injection works:
Kabidarba 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting increased red blood cell generation within the bone marrow, the blood-cell-producing tissue residing inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kabidarba 40 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Kabidarba 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Kabidarba 40 Injection while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Kabidarba 40 Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
Kabidarba 40 Injection poses no safety concerns for individuals with renal impairment and requires no dosage modification.
LiverCAUTION
Patients with hepatic impairment should use Kabidarba 40 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Kabidarba 40 Injection :
Should you forget a Kabidarba 40 Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Kabidarba 40 Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Action Class | Erythropoietin-stimulating drug |
3,018 People bought this recently